These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26045710)

  • 1. LRRFIP1 Inhibits Hepatitis C Virus Replication by Inducing Type I Interferon in Hepatocytes.
    Liu Y; Zou Z; Zhu B; Hu Z; Zeng P; Wu L
    Hepat Mon; 2015 May; 15(5):e28473. PubMed ID: 26045710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
    World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
    Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
    Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
    Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
    Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
    Zhang X; Zhu C; Wang T; Jiang H; Ren Y; Zhang Q; Wu K; Liu F; Liu Y; Wu J
    PLoS Pathog; 2017 Apr; 13(4):e1006321. PubMed ID: 28394926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucine-rich repeat (in Flightless I) interacting protein-1 regulates a rapid type I interferon response.
    Bagashev A; Fitzgerald MC; Larosa DF; Rose PP; Cherry S; Johnson AC; Sullivan KE
    J Interferon Cytokine Res; 2010 Nov; 30(11):843-52. PubMed ID: 20586614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response.
    Bauhofer O; Ruggieri A; Schmid B; Schirmacher P; Bartenschlager R
    Gastroenterology; 2012 Aug; 143(2):429-38.e8. PubMed ID: 22522091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated gene transfer of interferon alpha inhibits hepatitis C virus replication in hepatocytes.
    Suzuki K; Aoki K; Ohnami S; Yoshida K; Kazui T; Kato N; Inoue K; Kohara M; Yoshida T
    Biochem Biophys Res Commun; 2003 Aug; 307(4):814-9. PubMed ID: 12878183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
    MacParland SA; Ma XZ; Chen L; Khattar R; Cherepanov V; Selzner M; Feld JJ; Selzner N; McGilvray ID
    J Virol; 2016 Jun; 90(12):5549-5560. PubMed ID: 27009955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes.
    Wang Y; Li J; Wang X; Zhou Y; Zhang T; Ho W
    Hepat Mon; 2015 Aug; 15(8):e29282. PubMed ID: 26322111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication.
    Giugliano S; Kriss M; Golden-Mason L; Dobrinskikh E; Stone AE; Soto-Gutierrez A; Mitchell A; Khetani SR; Yamane D; Stoddard M; Li H; Shaw GM; Edwards MG; Lemon SM; Gale M; Shah VH; Rosen HR
    Gastroenterology; 2015 Feb; 148(2):392-402.e13. PubMed ID: 25447848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
    Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
    Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of silent information regulator-1 in hepatocytes induces lipid metabolism disorders and enhances hepatitis C virus replication].
    Sun LJ; Zhao YH; Li SC; Yu JW; Kang P; Liu W
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):834-9. PubMed ID: 24331693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.